US6602677B1
(en)
*
|
1997-09-19 |
2003-08-05 |
Promega Corporation |
Thermostable luciferases and methods of production
|
GB9823468D0
(en)
*
|
1998-10-28 |
1998-12-23 |
Secr Defence |
Novel enzyme
|
GB9925161D0
(en)
*
|
1999-10-26 |
1999-12-22 |
Secr Defence |
Novel enzyme
|
CA2387691A1
(en)
*
|
1999-10-26 |
2001-05-03 |
The Secretary Of State For Defence |
Novel enzyme
|
US7879540B1
(en)
*
|
2000-08-24 |
2011-02-01 |
Promega Corporation |
Synthetic nucleic acid molecule compositions and methods of preparation
|
US20030157643A1
(en)
*
|
2000-08-24 |
2003-08-21 |
Almond Brian D |
Synthetic nucleic acids from aquatic species
|
US7083911B2
(en)
|
2001-02-16 |
2006-08-01 |
Promega Corporation |
Method for detection of ATP
|
GB0111275D0
(en)
|
2001-05-09 |
2001-06-27 |
Secr Defence |
Analytical method and kit
|
EP1546162B1
(de)
|
2002-09-20 |
2011-06-22 |
Promega Corporation |
Auf lumineszenz basierende verfahren und sonden zur messung der cytochrom-p450-aktivität
|
CA2508072A1
(en)
|
2002-12-23 |
2004-07-15 |
Promega Corporation |
Protecting luciferase activity from luciferase enzyme interfering compounds using detergents for the accurate measurement of luciferase activity
|
DE10315640A1
(de)
*
|
2003-04-04 |
2004-10-14 |
Ignatov, Konstantin |
Verfahren zur kontrollierten Freisetzung von Komponenten in eine Lösung
|
EP1687399A4
(de)
*
|
2003-10-03 |
2007-09-05 |
Univ Michigan Tech |
Modifizierte luciferase
|
WO2005038029A2
(en)
|
2003-10-10 |
2005-04-28 |
Promega Corporation |
Luciferase biosensor
|
KR101520209B1
(ko)
|
2003-11-06 |
2015-05-13 |
시애틀 지네틱스, 인크. |
리간드에 접합될 수 있는 모노메틸발린 화합물
|
NZ551180A
(en)
|
2004-06-01 |
2009-10-30 |
Genentech Inc |
Antibody drug conjugates and methods
|
DK1763584T3
(da)
*
|
2004-07-02 |
2009-08-03 |
Promega Corp |
Sammensætninger og fremgangsmåde til ekstraktionen og detektionen af mikrobiel ATP
|
US7728118B2
(en)
*
|
2004-09-17 |
2010-06-01 |
Promega Corporation |
Synthetic nucleic acid molecule compositions and methods of preparation
|
EP1791565B1
(de)
|
2004-09-23 |
2016-04-20 |
Genentech, Inc. |
Zystein-modifizierte Antikörper und Konjugate
|
US8288352B2
(en)
|
2004-11-12 |
2012-10-16 |
Seattle Genetics, Inc. |
Auristatins having an aminobenzoic acid unit at the N terminus
|
EP2272973B1
(de)
|
2005-05-31 |
2015-05-27 |
Promega Corporation |
Luminogene und fluorogene Verbindungen und Verfahren für den Nachweis von Molekülen oder Leiden
|
EP1935986B1
(de)
|
2005-05-31 |
2014-04-16 |
Promega Corporation |
Luminogene und fluorogene Verbindungen und Verfahren für den Nachweis von Molekülen oder Leiden
|
GB0513535D0
(en)
*
|
2005-07-01 |
2005-08-10 |
Iseao Technologies Ltd |
Improved methods of detecting microbes
|
CA2614436C
(en)
|
2005-07-07 |
2016-05-17 |
Seattle Genetics, Inc. |
Monomethylvaline compounds having phenylalanine side-chain modifications at the c-terminus
|
GB0516455D0
(en)
*
|
2005-08-10 |
2005-09-14 |
Lumora Ltd |
pH tolerant luciferase
|
GB0517005D0
(en)
|
2005-08-19 |
2005-09-28 |
Enigma Diagnostics Ltd |
Analytical method and kit
|
EP2004813B1
(de)
*
|
2006-04-03 |
2015-06-03 |
Promega Corporation |
Permutierte und nichtpermutierte Luciferase-biosensoren, die zyklische Nukleotiden binden
|
AR060978A1
(es)
|
2006-05-30 |
2008-07-23 |
Genentech Inc |
Anticuerpos e inmunoconjugados y sus usos
|
CA2662236A1
(en)
|
2006-09-12 |
2008-03-20 |
Genentech, Inc. |
Methods and compositions for the diagnosis and treatment of cancer
|
SI2502938T1
(sl)
|
2006-10-27 |
2015-05-29 |
Genentech, Inc. |
Protitelesa in imunokonjugati in njihove uporabe
|
US7888352B2
(en)
|
2006-12-07 |
2011-02-15 |
Piramed Limited |
Phosphoinositide 3-kinase inhibitor compounds and methods of use
|
TW200918089A
(en)
|
2007-07-16 |
2009-05-01 |
Genentech Inc |
Humanized anti-CD79b antibodies and immunoconjugates and methods of use
|
JP5469600B2
(ja)
|
2007-07-16 |
2014-04-16 |
ジェネンテック, インコーポレイテッド |
抗CD79b抗体及びイムノコンジュゲートとその使用方法
|
US7893059B2
(en)
|
2007-09-24 |
2011-02-22 |
Genentech, Inc. |
Thiazolopyrimidine PI3K inhibitor compounds and methods of use
|
SI2657253T1
(sl)
|
2008-01-31 |
2017-10-30 |
Genentech, Inc. |
Protitelesa proti CD79b in imunokonjugati in postopki za uporabo
|
DK2644194T3
(en)
|
2008-03-18 |
2017-07-03 |
Genentech Inc |
Combinations of an anti-HER2 antibody-drug conjugate and docetaxel
|
NO2842575T3
(de)
|
2008-03-18 |
2018-02-24 |
|
|
WO2009140662A1
(en)
*
|
2008-05-15 |
2009-11-19 |
Illumina, Inc. |
Engineered luciferases
|
US9045730B2
(en)
*
|
2008-05-19 |
2015-06-02 |
Promega Corporation |
Luciferase biosensors for cAMP
|
US7852663B2
(en)
|
2008-05-23 |
2010-12-14 |
Seagate Technology Llc |
Nonvolatile programmable logic gates and adders
|
JP2010004758A
(ja)
*
|
2008-06-24 |
2010-01-14 |
Probex Inc |
cyclicGMP検出方法
|
AU2009270988A1
(en)
|
2008-07-15 |
2010-01-21 |
Genentech, Inc. |
Anthracycline derivative conjugates, process for their preparation and their use as antitumor compounds
|
EP2326953B1
(de)
|
2008-07-22 |
2018-03-21 |
Promega Corporation |
Auf adp-nachweis basierendes phosphotransferase- oder atp-hydrolase-lumineszenztestverfahren
|
WO2010021686A1
(en)
|
2008-08-18 |
2010-02-25 |
Promega Corporation |
Luminogenic compounds and methods to detect cytochrome p450 3a enzymes
|
US7985994B2
(en)
|
2008-09-29 |
2011-07-26 |
Seagate Technology Llc |
Flux-closed STRAM with electronically reflective insulative spacer
|
US8089132B2
(en)
|
2008-10-09 |
2012-01-03 |
Seagate Technology Llc |
Magnetic memory with phonon glass electron crystal material
|
US8045366B2
(en)
|
2008-11-05 |
2011-10-25 |
Seagate Technology Llc |
STRAM with composite free magnetic element
|
US8289756B2
(en)
|
2008-11-25 |
2012-10-16 |
Seagate Technology Llc |
Non volatile memory including stabilizing structures
|
US7826259B2
(en)
|
2009-01-29 |
2010-11-02 |
Seagate Technology Llc |
Staggered STRAM cell
|
UA103918C2
(en)
|
2009-03-02 |
2013-12-10 |
Айерем Элелси |
N-(hetero)aryl, 2-(hetero)aryl-substituted acetamides for use as wnt signaling modulators
|
BRPI1006189A2
(pt)
|
2009-03-12 |
2020-08-18 |
Genentech Inc |
uso de uma combinação terapêutica, formulação farmacêutica, artigo de manufatura, produto, método para determinar compostos a serem utilizados em combinação para o tratamento de uma malignidade hematopoiética e método para selecionar compostos a serem utilizados em combinação para o tratamento de câncer
|
AU2010236787A1
(en)
|
2009-04-01 |
2011-11-10 |
Genentech, Inc. |
Anti-FcRH5 antibodies and immunoconjugates and methods of use
|
EP2448966B1
(de)
|
2009-07-03 |
2018-11-14 |
Avipep Pty Ltd |
Immunkonjugate und verfahren zu ihrer herstellung
|
US8102703B2
(en)
*
|
2009-07-14 |
2012-01-24 |
Crocus Technology |
Magnetic element with a fast spin transfer torque writing procedure
|
JP5567136B2
(ja)
|
2009-09-08 |
2014-08-06 |
エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト |
4−置換ピリジン−3−イル−カルボキサミド化合物及び使用方法
|
ES2558742T3
(es)
|
2009-09-28 |
2016-02-08 |
F. Hoffmann-La Roche Ag |
Compuestos inhibidores de PI3K de benzoxepina y métodos de uso
|
MX2012003591A
(es)
|
2009-09-28 |
2012-04-19 |
Hoffmann La Roche |
Compuestos de benzoxazepina como inhibidores de la pi3k y metodos de uso.
|
EP2507381A4
(de)
|
2009-12-04 |
2016-07-20 |
Hoffmann La Roche |
Multispezifische antikörper, antikörperanaloge, zusammensetzungen und verfahren
|
CA2784610C
(en)
|
2009-12-23 |
2020-07-14 |
Avipep Pty Ltd |
Immuno-conjugates and methods for producing them
|
JP5981853B2
(ja)
|
2010-02-18 |
2016-08-31 |
ジェネンテック, インコーポレイテッド |
ニューレグリンアンタゴニスト及び癌の治療におけるそれらの使用
|
KR101738203B1
(ko)
|
2010-04-15 |
2017-05-19 |
메디뮨 리미티드 |
피롤로벤조디아제핀 및 그의 컨주게이트
|
EP2569423B1
(de)
*
|
2010-05-11 |
2015-12-02 |
Promega Corporation |
Mutante prothease-biosensoren mit verbesserten erkennungseigenschaften
|
US9290794B2
(en)
|
2010-05-11 |
2016-03-22 |
Promega Corporation |
Mutant protease biosensors with enhanced detection characteristics
|
BR112012029866A2
(pt)
|
2010-06-03 |
2017-03-07 |
Genentech Inc |
método para a determinação da presença de uma proteína steap-1
|
CA3220104A1
(en)
|
2010-06-08 |
2011-12-15 |
Genentech, Inc. |
Cysteine engineered antibodies and conjugates
|
RU2577986C2
(ru)
|
2010-06-18 |
2016-03-20 |
Дженентек, Инк. |
Антитела против axl и способы их применения
|
UY33469A
(es)
|
2010-06-29 |
2012-01-31 |
Irm Llc Y Novartis Ag |
Composiciones y metodos para modular la via de señalizacion de wnt
|
BR112013010855A2
(pt)
|
2010-11-02 |
2017-06-27 |
Promega Corp |
luciferases derivadas de oplophorus, novos substratos de coelenterazina e métodos de uso
|
SG189494A1
(en)
|
2010-11-02 |
2013-05-31 |
Promega Corp |
Coelenterazine derivatives and methods of using same
|
US20120121615A1
(en)
|
2010-11-17 |
2012-05-17 |
Flygare John A |
Alaninyl maytansinol antibody conjugates
|
AR084312A1
(es)
|
2010-12-16 |
2013-05-08 |
Genentech Inc |
Compuestos triciclicos inhibidores de la pi3k y composiciones farmaceuticas
|
MX345519B
(es)
|
2010-12-20 |
2017-02-01 |
Genentech Inc |
Anticuerpos anti-mesotelina e inmunoconjugados.
|
US9044518B2
(en)
|
2011-03-30 |
2015-06-02 |
Arizona Board Of Regents, A Body Corporate Of The State Of Arizona Acting For And On Behalf Of Arizona State University |
Auristatin tyramine phosphate salts and auristatin aminoquinoline derivatives and prodrugs thereof
|
CN103841976A
(zh)
|
2011-04-01 |
2014-06-04 |
基因泰克公司 |
Akt和mek抑制剂化合物的组合及其使用方法
|
SG194048A1
(en)
|
2011-04-01 |
2013-11-29 |
Genentech Inc |
Combinations of akt inhibitor compounds and chemotherapeutic agents, and methods of use
|
JP2014516511A
(ja)
|
2011-04-07 |
2014-07-17 |
ジェネンテック, インコーポレイテッド |
抗fgfr4抗体及び使用方法
|
EP2710018B8
(de)
|
2011-05-19 |
2022-02-23 |
Fundación del Sector Público Estatal Centro Nacional de Investigaciones Oncológicas Carlos III (F.S.P. CNIO) |
Makrozyklische verbindungen als proteinkinaseinhibitoren
|
EP2524918A1
(de)
|
2011-05-19 |
2012-11-21 |
Centro Nacional de Investigaciones Oncológicas (CNIO) |
Imidazopyrazinderivate als Kinase Inhibitoren
|
MX2014001766A
(es)
|
2011-08-17 |
2014-05-01 |
Genentech Inc |
Anticuerpos de neuregulina y sus usos.
|
EP2750713B1
(de)
|
2011-10-14 |
2015-09-16 |
Spirogen Sàrl |
Pyrrolobenzodiazepine und konjugate daraus
|
RU2622391C2
(ru)
|
2011-11-03 |
2017-06-15 |
Ф. Хоффманн-Ля Рош Аг |
Соединения 8-фторфталазин-1(2н)-она в качестве ингибиторов тирозинкиназы брутона
|
UA111756C2
(uk)
|
2011-11-03 |
2016-06-10 |
Ф. Хоффманн-Ля Рош Аг |
Сполуки гетероарилпіридону та азапіридону як інгібітори тирозинкінази брутона
|
ES2552514T3
(es)
|
2011-11-03 |
2015-11-30 |
Hoffmann-La Roche Ag |
Compuestos bicíclicos de piperazina
|
PE20141686A1
(es)
|
2011-11-03 |
2014-11-08 |
Hoffmann La Roche |
Compuestos de piperazina alquilados como inhibidores de actividad btk
|
US9271924B2
(en)
|
2011-11-08 |
2016-03-01 |
The Procter & Gamble Company |
Method of identifying prebiotics and compositions containing the same
|
EP2776573A1
(de)
*
|
2011-11-11 |
2014-09-17 |
Promega Corporation |
Mutante protease-biosensoren mit verbesserten erkennungseigenschaften
|
SG11201402619VA
(en)
|
2011-11-23 |
2014-10-30 |
Igenica Biotherapeutics Inc |
Anti-cd98 antibodies and methods of use thereof
|
AR090549A1
(es)
|
2012-03-30 |
2014-11-19 |
Genentech Inc |
Anticuerpos anti-lgr5 e inmunoconjugados
|
RU2014148162A
(ru)
|
2012-05-01 |
2016-06-20 |
Дженентек, Инк. |
Анти-pmel17 антитела и их иммуноконъюгаты
|
WO2013184766A1
(en)
|
2012-06-06 |
2013-12-12 |
Irm Llc |
Compounds and compositions for modulating egfr activity
|
JO3300B1
(ar)
|
2012-06-06 |
2018-09-16 |
Novartis Ag |
مركبات وتركيبات لتعديل نشاط egfr
|
MX2014014831A
(es)
|
2012-06-08 |
2015-02-12 |
Hoffmann La Roche |
Selectividad de mutante y combinaciones de un compuesto inhibidor de fosfoinositida 3 cinasa y agentes quimioterapeuticos para el tratamiento de cancer.
|
CA2874904A1
(en)
|
2012-07-09 |
2014-01-16 |
Genentech, Inc. |
Immunoconjugates comprising anti-cd22 antibodies
|
TW201408698A
(zh)
|
2012-07-09 |
2014-03-01 |
Genentech Inc |
抗cd79b抗體及免疫結合物
|
SG11201500096YA
(en)
|
2012-07-09 |
2015-02-27 |
Genentech Inc |
Immunoconjugates comprising anti - cd79b antibodies
|
SG11201500087VA
(en)
|
2012-07-09 |
2015-02-27 |
Genentech Inc |
Immunoconjugates comprising anti-cd22 antibodies
|
KR101697444B1
(ko)
|
2012-08-30 |
2017-01-17 |
에프. 호프만-라 로슈 아게 |
다이옥시노- 및 옥사진-[2,3-d]피리미딘 pi3k 억제제 화합물 및 사용 방법
|
WO2014059028A1
(en)
|
2012-10-09 |
2014-04-17 |
Igenica, Inc. |
Anti-c16orf54 antibodies and methods of use thereof
|
SI2906253T1
(sl)
|
2012-10-12 |
2018-11-30 |
Adc Therapeutics Sa |
Konjugati pirolobenzodiazepin-protitelo proti PSMA
|
HUE045435T2
(hu)
|
2012-10-12 |
2019-12-30 |
Medimmune Ltd |
Pirrolobenzodiazepinek és konjugátumaik
|
WO2014057120A1
(en)
|
2012-10-12 |
2014-04-17 |
Adc Therapeutics Sàrl |
Pyrrolobenzodiazepine-antibody conjugates
|
EP2906248B1
(de)
|
2012-10-12 |
2018-12-05 |
MedImmune Limited |
Pyrrolobenzodiazepine und konjugate davon
|
AU2013328625B2
(en)
|
2012-10-12 |
2016-12-15 |
Adc Therapeutics Sa |
Pyrrolobenzodiazepine-antibody conjugates
|
ES2680153T3
(es)
|
2012-10-12 |
2018-09-04 |
Adc Therapeutics Sa |
Conjugados de anticuerpos anti-PSMA-pirrolobenzodiazepinas
|
BR112015008238A2
(pt)
|
2012-10-12 |
2017-11-28 |
Adc Therapeutics Sarl |
conjugados de pirrolbenzodiazepina-anticorpo anti-cd22
|
HUE042731T2
(hu)
|
2012-10-12 |
2019-07-29 |
Adc Therapeutics Sa |
Pirrolobenzodiazepin-antitest konjugátumok
|
EA032986B1
(ru)
|
2012-12-21 |
2019-08-30 |
Медимьюн Лимитед |
Пирролобензодиазепины
|
JP6307519B2
(ja)
|
2012-12-21 |
2018-04-04 |
メドイミューン・リミテッドMedImmune Limited |
ピロロベンゾジアゼピンおよびその結合体
|
CN117701675A
(zh)
*
|
2013-02-22 |
2024-03-15 |
普洛麦格公司 |
用于荧光素酶和核苷磷酸的发光检测的稳定制剂
|
JP6669500B2
(ja)
|
2013-02-25 |
2020-03-18 |
ジェネンテック, インコーポレイテッド |
薬物耐性akt変異体を検出し治療するための方法及び組成物
|
EA027910B1
(ru)
|
2013-03-13 |
2017-09-29 |
Медимьюн Лимитед |
Пирролобензодиазепины и их конъюгаты
|
JP6340019B2
(ja)
|
2013-03-13 |
2018-06-06 |
メドイミューン・リミテッドMedImmune Limited |
ピロロベンゾジアゼピン及びそのコンジュゲート
|
CA2905181C
(en)
|
2013-03-13 |
2020-06-02 |
Medimmune Limited |
Pyrrolobenzodiazepines and conjugates thereof for providing targeted therapy
|
WO2014159835A1
(en)
|
2013-03-14 |
2014-10-02 |
Genentech, Inc. |
Anti-b7-h4 antibodies and immunoconjugates
|
JP6527132B2
(ja)
|
2013-03-15 |
2019-06-05 |
ジェネンテック, インコーポレイテッド |
肝臓がんの診断及び治療のための組成物及び方法
|
AR095443A1
(es)
|
2013-03-15 |
2015-10-14 |
Fundación Centro Nac De Investig Oncológicas Carlos Iii |
Heterociclos condensados con acción sobre atr
|
KR101815360B1
(ko)
|
2013-07-03 |
2018-01-04 |
에프. 호프만-라 로슈 아게 |
헤테로아릴 피리돈 및 아자-피리돈 아마이드 화합물
|
MX2016001862A
(es)
|
2013-08-12 |
2016-08-03 |
Genentech Inc |
Compuestos de conjugado anticuerpo-farmaco dimerico de 1-(clorometil)-2,3-dihidro-1h-benzo[e]indol, y metodos de uso y tratamiento.
|
CN105518027A
(zh)
|
2013-09-17 |
2016-04-20 |
豪夫迈·罗氏有限公司 |
使用抗lgr5抗体的方法
|
EP3054983B1
(de)
|
2013-10-11 |
2019-03-20 |
Medimmune Limited |
Pyrrolobenzodiazepin-antikörper-konjugate
|
WO2015052534A1
(en)
|
2013-10-11 |
2015-04-16 |
Spirogen Sàrl |
Pyrrolobenzodiazepine-antibody conjugates
|
GB201317982D0
(en)
|
2013-10-11 |
2013-11-27 |
Spirogen Sarl |
Pyrrolobenzodiazepines and conjugates thereof
|
US9956299B2
(en)
|
2013-10-11 |
2018-05-01 |
Medimmune Limited |
Pyrrolobenzodiazepine—antibody conjugates
|
WO2015083059A1
(en)
|
2013-12-02 |
2015-06-11 |
Novartis Ag |
Forms of the egfr inhibitor
|
CA2929918C
(en)
|
2013-12-05 |
2018-01-23 |
F. Hoffmann-La Roche Ag |
Heteroaryl pyridone and aza-pyridone compounds with electrophilic functionality
|
MA39095A1
(fr)
|
2013-12-13 |
2018-08-31 |
Genentech Inc |
Anticorps et immunoconjugués anti-cd33
|
JP6980384B2
(ja)
|
2013-12-16 |
2021-12-15 |
ジェネンテック, インコーポレイテッド |
1−(クロロメチル)−2,3−ジヒドロ−1h−ベンゾ[e]インドール二量体抗体−薬物コンジュゲート化合物、並びに使用及び処置の方法
|
WO2015112909A1
(en)
|
2014-01-24 |
2015-07-30 |
Genentech, Inc. |
Methods of using anti-steap1 antibodies and immunoconjugates
|
US9790537B2
(en)
|
2014-01-29 |
2017-10-17 |
Promega Corporation |
Quinone-masked probes as labeling reagents for cell uptake measurements
|
EP3099691B1
(de)
|
2014-01-29 |
2019-11-20 |
Promega Corporation |
Pro-substrate für lebendzellanwendungen
|
MA39741A
(fr)
|
2014-03-13 |
2017-01-18 |
Hoffmann La Roche |
Combinaisons thérapeutiques avec des modulateurs du récepteur des œstrogènes
|
GB201406767D0
(en)
|
2014-04-15 |
2014-05-28 |
Cancer Rec Tech Ltd |
Humanized anti-Tn-MUC1 antibodies anf their conjugates
|
MX2016015162A
(es)
|
2014-05-22 |
2017-03-03 |
Genentech Inc |
Anticuerpos anti - gpc3 e inmunoconjugados.
|
JP2017526618A
(ja)
|
2014-06-11 |
2017-09-14 |
ジェネンテック, インコーポレイテッド |
抗LgR5抗体及びその使用
|
US10188746B2
(en)
|
2014-09-10 |
2019-01-29 |
Medimmune Limited |
Pyrrolobenzodiazepines and conjugates thereof
|
EP3191600A1
(de)
|
2014-09-11 |
2017-07-19 |
Promega Corporation |
Luciferasesequenzen unter verwendung von infrarotemittierenden substraten zur herstellung von verstärkter lumineszenz
|
EP3191134B1
(de)
|
2014-09-12 |
2019-11-20 |
Genentech, Inc. |
Anthracyclindisulfidzwischenprodukte, antikörper-wirkstoff-konjugate und verfahren
|
EA201790545A1
(ru)
|
2014-09-12 |
2017-07-31 |
Дженентек, Инк. |
Антитела и иммуноконъюгаты против her2
|
US9751946B2
(en)
|
2014-09-12 |
2017-09-05 |
Genentech, Inc. |
Anti-CLL-1 antibodies and immunoconjugates
|
CA2957354A1
(en)
|
2014-09-12 |
2016-03-17 |
Genentech, Inc. |
Cysteine engineered antibodies and conjugates
|
GB201416112D0
(en)
|
2014-09-12 |
2014-10-29 |
Medimmune Ltd |
Pyrrolobenzodiazepines and conjugates thereof
|
MX2017003523A
(es)
|
2014-09-17 |
2017-11-08 |
Genentech Inc |
Pirrolobenzodiazepinas y conjugados de anticuerpo-disulfuro de las mismas.
|
JP6730261B2
(ja)
|
2014-09-17 |
2020-07-29 |
ジェネンテック, インコーポレイテッド |
抗her2抗体を含む免疫複合体
|
JP6507234B2
(ja)
|
2014-10-02 |
2019-04-24 |
エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft |
ブルトンチロシンキナーゼ(btk)によって介入される障害の処置における使用のためのピラゾールカルボキサミド化合物
|
US9677117B2
(en)
|
2014-10-08 |
2017-06-13 |
Promega Corporation |
Bioluminescent succinate detection assay
|
CN107148285B
(zh)
|
2014-11-25 |
2022-01-04 |
Adc治疗股份有限公司 |
吡咯并苯并二氮杂䓬-抗体缀合物
|
GB201506402D0
(en)
|
2015-04-15 |
2015-05-27 |
Berkel Patricius H C Van And Howard Philip W |
Site-specific antibody-drug conjugates
|
GB201506389D0
(en)
|
2015-04-15 |
2015-05-27 |
Berkel Patricius H C Van And Howard Philip W |
Site-specific antibody-drug conjugates
|
GB201506411D0
(en)
|
2015-04-15 |
2015-05-27 |
Bergenbio As |
Humanized anti-axl antibodies
|
JP2018524295A
(ja)
|
2015-06-15 |
2018-08-30 |
ジェネンテック, インコーポレイテッド |
抗体及び免疫複合体
|
CN107847568B
(zh)
|
2015-06-16 |
2022-12-20 |
豪夫迈·罗氏有限公司 |
抗cll-1抗体和使用方法
|
DK3341376T3
(da)
|
2015-08-26 |
2021-03-29 |
Fundacion Del Sector Publico Estatal Centro Nac De Investigaciones Oncologicas Carlos Iii F S P Cnio |
Kondenserede tricykliske forbindelser som proteinkinase-inhibitorer
|
MA43345A
(fr)
|
2015-10-02 |
2018-08-08 |
Hoffmann La Roche |
Conjugués anticorps-médicaments de pyrrolobenzodiazépine et méthodes d'utilisation
|
MA43354A
(fr)
|
2015-10-16 |
2018-08-22 |
Genentech Inc |
Conjugués médicamenteux à pont disulfure encombré
|
MA45326A
(fr)
|
2015-10-20 |
2018-08-29 |
Genentech Inc |
Conjugués calichéamicine-anticorps-médicament et procédés d'utilisation
|
GB201601431D0
(en)
|
2016-01-26 |
2016-03-09 |
Medimmune Ltd |
Pyrrolobenzodiazepines
|
GB201602356D0
(en)
|
2016-02-10 |
2016-03-23 |
Medimmune Ltd |
Pyrrolobenzodiazepine Conjugates
|
GB201602359D0
(en)
|
2016-02-10 |
2016-03-23 |
Medimmune Ltd |
Pyrrolobenzodiazepine Conjugates
|
GB201607478D0
(en)
|
2016-04-29 |
2016-06-15 |
Medimmune Ltd |
Pyrrolobenzodiazepine Conjugates
|
EP3464280B1
(de)
|
2016-06-06 |
2021-10-06 |
F. Hoffmann-La Roche AG |
Silvestrol-antikörper-arzneimittelkonjugate und verfahren zur verwendung
|
JP6493316B2
(ja)
*
|
2016-06-21 |
2019-04-03 |
東亜ディーケーケー株式会社 |
変異型甲虫ルシフェラーゼ、遺伝子、組換えベクター、形質転換体、及び変異型甲虫ルシフェラーゼの製造方法
|
WO2018031662A1
(en)
|
2016-08-11 |
2018-02-15 |
Genentech, Inc. |
Pyrrolobenzodiazepine prodrugs and antibody conjugates thereof
|
WO2018053542A1
(en)
*
|
2016-09-19 |
2018-03-22 |
University Of Southern California |
Non-radioactive cytotoxicity assays
|
EP3526343A4
(de)
*
|
2016-10-13 |
2020-08-05 |
Promega Corporation |
Thermisch stabile luciferase mit verbessertem widerstand gegen die hemmung durch luciferinzerfallsprodukte
|
GB201617466D0
(en)
|
2016-10-14 |
2016-11-30 |
Medimmune Ltd |
Pyrrolobenzodiazepine conjugates
|
AU2017361887B2
(en)
|
2016-11-21 |
2019-08-15 |
Cureab Gmbh |
Anti-GP73 antibodies and immunoconjugates
|
ES2890934T3
(es)
|
2017-02-08 |
2022-01-25 |
Adc Therapeutics Sa |
Conjugados de pirrolobenzodiazepinas y anticuerpos
|
GB201702031D0
(en)
|
2017-02-08 |
2017-03-22 |
Medlmmune Ltd |
Pyrrolobenzodiazepine-antibody conjugates
|
JP6671555B2
(ja)
|
2017-02-08 |
2020-03-25 |
アーデーセー セラピューティクス ソシエテ アノニム |
ピロロベンゾジアゼピン抗体複合体
|
AU2018255876B2
(en)
|
2017-04-18 |
2020-04-30 |
Medimmune Limited |
Pyrrolobenzodiazepine conjugates
|
AU2018253948A1
(en)
|
2017-04-20 |
2019-09-19 |
Adc Therapeutics Sa |
Combination therapy with an anti-AXL Antibody-Drug Conjugate
|
MX2019015042A
(es)
|
2017-06-14 |
2020-08-06 |
Adc Therapeutics Sa |
Regimen de dosificacion.
|
WO2019028272A1
(en)
|
2017-08-04 |
2019-02-07 |
Promega Corporation |
COMPOSITIONS AND METHODS FOR STABILIZING LUCIFERIN BENZOTHIAZOLE ANALOGS
|
KR102270107B1
(ko)
|
2017-08-18 |
2021-06-30 |
메디뮨 리미티드 |
피롤로벤조디아제핀 컨쥬게이트
|
CN111788208B
(zh)
|
2017-09-20 |
2023-11-24 |
Ph制药有限公司 |
泰兰他汀类似物
|
GB201803342D0
(en)
|
2018-03-01 |
2018-04-18 |
Medimmune Ltd |
Methods
|
GB201806022D0
(en)
|
2018-04-12 |
2018-05-30 |
Medimmune Ltd |
Pyrrolobenzodiazepines and conjugates thereof
|
US11767517B2
(en)
*
|
2018-06-05 |
2023-09-26 |
Promega Corporation |
Luciferase enzymes for use with thermostable luciferins in bioluminescent assays
|
GB201908128D0
(en)
|
2019-06-07 |
2019-07-24 |
Adc Therapeutics Sa |
Pyrrolobenzodiazepine-antibody conjugates
|
US20230058982A1
(en)
|
2019-12-27 |
2023-02-23 |
Chugai Seiyaku Kabushiki Kaisha |
Anti-ctla-4 antibody and use thereof
|
TW202200212A
(zh)
|
2020-05-03 |
2022-01-01 |
中國大陸商聯寧(蘇州)生物製藥有限公司 |
包含抗-trop-2抗體之抗體藥物結合物
|
WO2021231400A1
(en)
|
2020-05-12 |
2021-11-18 |
Accutar Biotechnology, Inc. |
Bis-aryl ethers containing n-acyl azetidine as egfr/her2 inhibitors
|
JP2024501894A
(ja)
|
2021-01-04 |
2024-01-16 |
メルサナ セラピューティクス インコーポレイテッド |
B7h4ターゲティング抗体-薬物コンジュゲートおよびその使用方法
|
JP2024509169A
(ja)
|
2021-03-03 |
2024-02-29 |
ソレント・セラピューティクス・インコーポレイテッド |
抗bcma抗体を含む抗体-薬物コンジュゲート
|
EP4333822A1
(de)
|
2021-05-03 |
2024-03-13 |
Lead Discovery Center GmbH |
Zusammensetzung mit einem hemmer der mitochondrialen transkription
|
WO2022270612A1
(ja)
|
2021-06-25 |
2022-12-29 |
中外製薬株式会社 |
抗ctla-4抗体の使用
|
JP7472405B2
(ja)
|
2021-06-25 |
2024-04-22 |
中外製薬株式会社 |
抗ctla-4抗体
|
WO2023173026A1
(en)
|
2022-03-10 |
2023-09-14 |
Sorrento Therapeutics, Inc. |
Antibody-drug conjugates and uses thereof
|
WO2023215737A1
(en)
|
2022-05-03 |
2023-11-09 |
Genentech, Inc. |
Anti-ly6e antibodies, immunoconjugates, and uses thereof
|